First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 8.3 USD 3.36% Market Closed
Updated: May 20, 2024

Burning Rock Biotech Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Burning Rock Biotech Ltd
Cash Equivalents Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Burning Rock Biotech Ltd
NASDAQ:BNR
Cash Equivalents
¥615.1m
CAGR 3-Years
-31%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash Equivalents
¥1.4B
CAGR 3-Years
92%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Burning Rock Biotech Ltd's Cash Equivalents?
Cash Equivalents
615.1m CNY

Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Cash Equivalents amounts to 615.1m CNY.

What is Burning Rock Biotech Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
46%

Over the last year, the Cash Equivalents growth was -32%. The average annual Cash Equivalents growth rates for Burning Rock Biotech Ltd have been -31% over the past three years , 46% over the past five years .